Covestor Ltd - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$040.0%0.00%
Q2 2023$04
-20.0%
0.00%
Q1 2023$05
-50.0%
0.00%
Q4 2022$010
+100.0%
0.00%
Q3 2022$05
-16.7%
0.00%
Q2 2022$0
-100.0%
6
-95.3%
0.00%
-100.0%
Q1 2022$8,000
-82.6%
129
-70.0%
0.01%
-92.2%
Q4 2021$46,0004300.06%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders